Navigation Links
Ikaria Strengthens Executive Leadership Team
Date:10/2/2008

- Head of Engineering and Operations Appointed -

CLINTON, N.J., Oct. 2 /PRNewswire/ -- Ikaria Holdings, Inc. today announced the appointment of Michael Kennedy as Senior Vice President, Engineering and Operations. In this role, Kennedy will be responsible for drug-device technology strategy and development.

"Michael's extensive experience will help Ikaria strengthen its leadership in critical care as we continue to advance our pharmaceutical pipeline through a number of strategies including our strong commitment to drug-device development," said Daniel Tasse', President and CEO of Ikaria. "I am pleased to welcome Michael, who will complete our executive leadership team."

Most recently, Kennedy served as Vice President, Technology Platform Development in the Pharmaceutical and Technology Division of Baxter International Inc., where he led drug-device technology strategy and development across the organization's portfolio. Previously he led the global development of Baxter's industry-leading dialysis and transfusion therapy innovations. Kennedy's executive experience also includes senior positions at General Electric, Hollister Inc. and Comdisco Healthcare Group.

About Ikaria Holdings, Inc.

Ikaria Holdings, Inc. is a fully integrated biotherapeutics company focused on the development and commercialization of innovative pharmaceuticals, biologic messengers and drug-device combinations for hospitalized, critically ill patients. The company's lead product, INOmax(R) (nitric oxide) for inhalation, is the only FDA-approved drug for the treatment of hypoxic respiratory failure in term and near-term newborns, and also is marketed in Canada, Europe, Australia and Latin America. INOmax recently was approved for marketing in Japan. Ikaria is engaged in new and ongoing clinical development of INOmax, Covox(R) (carbon monoxide) for inhalation and hydrogen sulfide. Ikaria is headquartered in Clinton, NJ, with research facilities in Seattle
'/>"/>

SOURCE Ikaria Holdings, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Ikaria(R) Strengthens Commercial Operations and Human Resources Leadership
2. Ikaria Introduces Dr. Michael Cooreman as Vice President of Translational Medicine
3. Lota Zoth Elected to Ikaria Board and Named Audit Committee Chair
4. Ikaria Appoints Daniel Tasse as President and Chief Executive Officer
5. Ikaria to Present at 26th Annual JPMorgan Healthcare Conference
6. Ikaria Founding Scientist Named 2007 MacArthur Fellow
7. New Study Shows Promise for Hydrogen Sulfide in Reducing Heart-Attack Damage, Ikaria Announces
8. Algenol Biofuels Further Strengthens Team With Key Appointments
9. InNexus Biotechnology Strengthens Patent Team With New Leadership
10. InVitria Further Strengthens Sales Team with Promotion of Brandy Sargent to Account Manager - Western United States
11. Halozyme Therapeutics Strengthens Management Team, Appoints Additional Experienced Executives
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/7/2015)... , ... July 07, 2015 , ... ... driven community in the biometrical area. What began as a conference for European ... community for various functions in the biometrical area. Statistical Programmers, Data Managers and ...
(Date:7/7/2015)... ... 07, 2015 , ... The Pistoia Alliance, a global, not-for-profit ... science R&D, has attracted a number of new members from across the industry. ... joining as a Core member, and DNAnexus and Tessella as Participating members. Genexyx ...
(Date:7/6/2015)... ... July 06, 2015 , ... ... hosted their 2015 bi-annual Pain Management Medical Advisory Board meeting in Palm Springs, ... executive Research and Development team to discuss new clinical practice and research ideas. ...
(Date:7/6/2015)... ... July 06, 2015 , ... Discovery of new biomarkers ... key drivers of the global molecular diagnostics market. BCC Research reveals in its ... new companion diagnostic tests will increase demand for inexpensive and accurate tests for ...
Breaking Biology Technology:PhUSE Delighted to Welcome Member Number 5.000 2Pistoia Alliance Continues to Attract New Members 2Proove Biosciences Gathers Key Opinion Leaders in Pain Management for Medical Advisory Board Meeting in Palm Springs, California 2Proove Biosciences Gathers Key Opinion Leaders in Pain Management for Medical Advisory Board Meeting in Palm Springs, California 3Demand for Personalized Medicine, Innovative Molecular Diagnostic Tests Spurring Big Growth, According to BCC Research 2Demand for Personalized Medicine, Innovative Molecular Diagnostic Tests Spurring Big Growth, According to BCC Research 3
... Feb. 6 Thermo Fisher,Scientific Inc. (NYSE: TMO ... increased to a record $2.62 billion in the fourth ... 2006 merger with Fisher,Scientific), compared with $1.67 billion in ... $.54 in 2007, versus $0.08 in the year-ago,period. GAAP ...
... for detecting explosives and poisons could,be developed following new ... today (3 February) in Nature Photonics. , The ... far,infrared part of the electromagnetic spectrum that have a ... along the surface of a,specially designed material, known as ...
... Quest Executive Director Brings Extensive Strategic Marketing ... ... Transgenomic, Inc. (OTC,Bulletin Board: TBIO), today announced that it has appointed ... a consultant,at Water Street Healthcare Partners, a Chicago-based private equity firm,specializing ...
Cached Biology Technology:Thermo Fisher Scientific Reports Record 2007 Fourth Quarter Revenues and Operating Performance; Provides Guidance for 2008 2Thermo Fisher Scientific Reports Record 2007 Fourth Quarter Revenues and Operating Performance; Provides Guidance for 2008 3Thermo Fisher Scientific Reports Record 2007 Fourth Quarter Revenues and Operating Performance; Provides Guidance for 2008 4Thermo Fisher Scientific Reports Record 2007 Fourth Quarter Revenues and Operating Performance; Provides Guidance for 2008 5Thermo Fisher Scientific Reports Record 2007 Fourth Quarter Revenues and Operating Performance; Provides Guidance for 2008 6Thermo Fisher Scientific Reports Record 2007 Fourth Quarter Revenues and Operating Performance; Provides Guidance for 2008 7Thermo Fisher Scientific Reports Record 2007 Fourth Quarter Revenues and Operating Performance; Provides Guidance for 2008 8Thermo Fisher Scientific Reports Record 2007 Fourth Quarter Revenues and Operating Performance; Provides Guidance for 2008 9Thermo Fisher Scientific Reports Record 2007 Fourth Quarter Revenues and Operating Performance; Provides Guidance for 2008 10Thermo Fisher Scientific Reports Record 2007 Fourth Quarter Revenues and Operating Performance; Provides Guidance for 2008 11Thermo Fisher Scientific Reports Record 2007 Fourth Quarter Revenues and Operating Performance; Provides Guidance for 2008 12Thermo Fisher Scientific Reports Record 2007 Fourth Quarter Revenues and Operating Performance; Provides Guidance for 2008 13Thermo Fisher Scientific Reports Record 2007 Fourth Quarter Revenues and Operating Performance; Provides Guidance for 2008 14Thermo Fisher Scientific Reports Record 2007 Fourth Quarter Revenues and Operating Performance; Provides Guidance for 2008 15Thermo Fisher Scientific Reports Record 2007 Fourth Quarter Revenues and Operating Performance; Provides Guidance for 2008 16Thermo Fisher Scientific Reports Record 2007 Fourth Quarter Revenues and Operating Performance; Provides Guidance for 2008 17Thermo Fisher Scientific Reports Record 2007 Fourth Quarter Revenues and Operating Performance; Provides Guidance for 2008 18Thermo Fisher Scientific Reports Record 2007 Fourth Quarter Revenues and Operating Performance; Provides Guidance for 2008 19Thermo Fisher Scientific Reports Record 2007 Fourth Quarter Revenues and Operating Performance; Provides Guidance for 2008 20Thermo Fisher Scientific Reports Record 2007 Fourth Quarter Revenues and Operating Performance; Provides Guidance for 2008 21Thermo Fisher Scientific Reports Record 2007 Fourth Quarter Revenues and Operating Performance; Provides Guidance for 2008 22'T-ray' breakthrough signals next generation of security sensors 2Transgenomic Appoints David Pauluzzi to Board of Directors 2Transgenomic Appoints David Pauluzzi to Board of Directors 3
(Date:6/15/2015)... 2015 NXT-ID, Inc. (NASDAQ: NXTD ) ("NXT-ID" or ... mobile commerce market, announces that its leading payment security technology, ... Digital Experience! @ NYC June 18th. Digital Experience! ... innovation in technology to over 300 of the top media ... Metropolitan Pavilion in New York City ...
(Date:6/11/2015)... Va. , June 11, 2015 ... technology, announced today that its IdentityX Mobile Authentication ... (Fast IDentity Online) Alliance is an industry consortium ... open standards for simpler, stronger authentication.  In order ... must pass a rigorous series of tests that ...
(Date:6/9/2015)... 9, 2015   MedNet Solutions , an innovative ... of clinical research, will be providing demonstrations of its ... the 2015 Drug Information Association (DIA) Annual Meeting in ... These presentations will include previews of many exciting new ... upcoming iMedNet 2015 Feature 1 Release. ...
Breaking Biology News(10 mins):Wocket Smart Wallet Exhibiting at Pepcom Digital Experience! @ NYC June 18th 2Wocket Smart Wallet Exhibiting at Pepcom Digital Experience! @ NYC June 18th 3Daon's IdentityX Mobile Authentication Platform One of First Products to be Certified by FIDO Alliance 2MedNet To Provide Sneak Peeks Of Its iMedNet "2015 Feature 1 Release" At The DIA Annual Meeting 2MedNet To Provide Sneak Peeks Of Its iMedNet "2015 Feature 1 Release" At The DIA Annual Meeting 3
... -- or mother of pearl, scientists and artisans know, is ... a multitude of mollusk species, nacre is widely used in ... and decorative boxes. Fashioned into buttons, beads and a host ... lends a lustrous iridescence to everyday objects. In recent ...
... Severe heart damage in people who are obese and diabetic ... researchers have found. In the failing hearts of ... of proteins, small fibers and plaques made of amylin, the ... They also showed in an animal model that amylin accumulation ...
... half of near stagnation, four new drugs could help make ... disease, a leading Colorado prostate cancer expert says. "It,s ... of action. One is a bone protective agent; another,s a ... one is the first drug tested for cancer immunotherapy," says ...
Cached Biology News:Mother of pearl tells a tale of ocean temperature, depth 2Pancreatic hormone linked with severe heart disease in obese and diabetic patients 24 new drugs will change prostate cancer care 2
Agarose-LE, 250 g. Suitable for soft agarose cloning. Nuclease-free.Gel point (1.5%): 36 1.5 C, EEO (-mr): 1200 g/cm2. Category: Nucleotides & Enzymes & Biochemicals, Ultrapure Biochemicals ....
Request Info...
Request Info...
Agarose-LE, 500 g. Suitable for soft agarose cloning. Nuclease-free.Gel point (1.5%): 36 1.5 C, EEO (-mr): 1200 g/cm2. Category: Nucleotides & Enzymes & Biochemicals, Ultrapure Biochemicals ....
Biology Products: